載入...
Raloxifene administration enhances retention in an orthodontic relapse model
BACKGROUND AND OBJECTIVES: Orthodontic relapse is a physiologic process that involves remodelling of the alveolar bone and principle periodontal ligament fibres. Raloxifene is an Food and Drug Administration (FDA)-approved selective oestrogen receptor modulator that inhibits systemic bone loss. In o...
Na minha lista:
| 發表在: | Eur J Orthod |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7485273/ https://ncbi.nlm.nih.gov/pubmed/32065225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ejo/cjaa008 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|